GILD—this [new trial] may be driven by pricing considerations, especially with respect to emerging markets - there is more room for premium pricing SOF if there is no additional cost of LED or Peg-IFN.
Your explanation is consistent with the information in #msg-89871936.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”